Torpharm generic Cardizem CD approved
Executive Summary
Apotex subsidiary Torpharm's diltiazem extended-release capsules approved May 20 in 120 mg, 180 mg, 240 mg, and 300 mg strengths. Reference listed drug is Biovail's Cardizem CD (1"The Pink Sheet" May 24, 2004, p. 38)...
You may also be interested in...
Chart: FDA’s ANDA Approvals
FDA's ANDA Approvals
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.